In This Article:
As global markets grapple with inflation concerns and trade uncertainties, the Asian market presents a unique landscape where opportunities for investment can still be found. In this environment, identifying stocks that are potentially undervalued compared to their intrinsic value becomes crucial for investors seeking to navigate the complexities of current economic conditions.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Sichuan Kexin Mechanical and Electrical EquipmentLtd (SZSE:300092) | CN¥13.07 | CN¥25.75 | 49.2% |
| CS Wind (KOSE:A112610) | ₩38100.00 | ₩75868.66 | 49.8% |
| Cosmax (KOSE:A192820) | ₩179900.00 | ₩356090.86 | 49.5% |
| S Foods (TSE:2292) | ¥2586.00 | ¥5084.09 | 49.1% |
| Takara Bio (TSE:4974) | ¥853.00 | ¥1696.74 | 49.7% |
| APAC Realty (SGX:CLN) | SGD0.43 | SGD0.85 | 49.6% |
| JSHLtd (TSE:150A) | ¥558.00 | ¥1106.93 | 49.6% |
| Sunny Optical Technology (Group) (SEHK:2382) | HK$88.50 | HK$175.51 | 49.6% |
| BalnibarbiLtd (TSE:3418) | ¥1120.00 | ¥2205.09 | 49.2% |
| Doosan Fuel Cell (KOSE:A336260) | ₩16000.00 | ₩31633.38 | 49.4% |
We'll examine a selection from our screener results.
Genscript Biotech
Overview: Genscript Biotech Corporation is an investment holding company that manufactures and sells life science research products and services globally, with a market cap of approximately HK$28.56 billion.
Operations: The company's revenue is primarily derived from Life Science Services and Products at $454.95 million, followed by Biologics Development Services at $95.02 million, Industrial Synthetic Biology Products at $53.69 million, and Operation Unit activities contributing $56.89 million.
Estimated Discount To Fair Value: 34.6%
Genscript Biotech is trading significantly below its estimated fair value, with a current price of HK$13.3 compared to an estimated fair value of HK$20.33, suggesting potential undervaluation based on cash flows. The company reported substantial net income growth for 2024, indicating improved financial health and profitability prospects over the next three years. Despite slower revenue growth forecasts than 20% annually, it still surpasses the Hong Kong market average, highlighting its competitive edge in revenue generation.
Newborn Town
Overview: Newborn Town Inc. is an investment holding company that operates in the social networking sector globally, with a market capitalization of HK$9.26 billion.